Home » News » Progress Made in Developing Methamphetamine Vaccine

Progress Made in Developing Methamphetamine Vaccine

Progress Made in Developing Methamphetamine Vaccine Researchers report promising advances in the lab toward the development of a vaccine to treat methamphetamine addiction.

Although the abuse of “speed” or methamphetamines is under the radar screen for many, the costs associated with the addiction are astronomical exceeding $23 billion annually. Expenditures include medical and law enforcement outlays as well as lost productivity.

In the paper, Kim Janda, Ph.D., and colleagues note that “meth” or “crystal meth” can cause a variety of problems including cardiovascular damage and death. Meth is highly addictive, and users in conventional behavioral treatment programs often relapse.

Earlier forms of vaccines for methamphetamine addiction were ineffective or are very expensive. As a consequence, researchers made and tested new vaccine formulations that could potentially be effective for long periods, which would drive down costs and help prevent relapse.

The group found that three of the new formulations that produced a good immune response in mice (stand-ins for humans in the lab) were particularly promising.

“These findings represent a unique approach to the design of new vaccines against methamphetamine abuse,” the researchers said.

The report appears in the Journal of the American Chemical Society.

Source: American Chemical Society

Progress Made in Developing Methamphetamine Vaccine

Rick Nauert PhD

Rick Nauert, PhDDr. Rick Nauert has over 25 years experience in clinical, administrative and academic healthcare. He is currently an associate professor for Rocky Mountain University of Health Professionals doctoral program in health promotion and wellness. Dr. Nauert began his career as a clinical physical therapist and served as a regional manager for a publicly traded multidisciplinary rehabilitation agency for 12 years. He has masters degrees in health-fitness management and healthcare administration and a doctoral degree from The University of Texas at Austin focused on health care informatics, health administration, health education and health policy. His research efforts included the area of telehealth with a specialty in disease management.

APA Reference
Nauert PhD, R. (2015). Progress Made in Developing Methamphetamine Vaccine. Psych Central. Retrieved on May 22, 2018, from https://psychcentral.com/news/2011/05/12/progress-made-in-developing-methamphetamine-vaccine/26103.html

 

Scientifically Reviewed
Last updated: 6 Oct 2015
Last reviewed: By John M. Grohol, Psy.D. on 6 Oct 2015
Published on PsychCentral.com. All rights reserved.